Trivant Custom Portfolio Group, LLC Astrazeneca PLC Transaction History

Trivant Custom Portfolio Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$61.03 - $69.57 $55,964 - $63,795	917 Added 5.71%	16,978 $1.15 Billion
Q4 2023 Jan 25, 2024	SELL	$61.89 - $69.28 $206,774 - $231,464	-3,341 Reduced 17.22%	16,061 $1.08 Billion
Q3 2023 Nov 02, 2023	BUY	$64.85 - $71.7 $31,257 - $34,559	482 Added 2.55%	19,402 $1.31 Billion
Q2 2023 Jul 26, 2023	BUY	$69.91 - $75.81 $1.32 Million - $1.43 Million	18,920 New	18,920 $1.35 Billion

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Trivant Custom Portfolio Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Trivant Custom Portfolio Group, LLC with notifications on news.